We first identified LEF1 as a central hub gene for AAA by DEG screening and LASSO regression; then, we found its predominant expression in T cells infiltrated within AAA lesions using scRNA‐seq, and functional enrichment linked LEF1 to immune pathways (e.g., T cell activation, MHC binding). This evidence concerns the gene LEF1 and triple-A syndrome.